Annual Cash & Cash Equivalents
$594.00 M
+$314.17 M+112.27%
31 December 2023
Summary:
PTC Therapeutics annual cash & cash equivalents is currently $594.00 million, with the most recent change of +$314.17 million (+112.27%) on 31 December 2023. During the last 3 years, it has risen by +$385.19 million (+184.47%). PTCT annual cash & cash equivalents is now at all-time high.PTCT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$526.00 M
-$128.78 M-19.67%
30 September 2024
Summary:
PTC Therapeutics quarterly cash and cash equivalents is currently $526.00 million, with the most recent change of -$128.78 million (-19.67%) on 30 September 2024. Over the past year, it has increased by +$360.84 million (+218.49%). PTCT quarterly cash and cash equivalents is now -19.67% below its all-time high of $654.78 million, reached on 30 June 2024.PTCT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +112.3% | +218.5% |
| 3 y3 years | +184.5% | +177.1% |
| 5 y5 years | +250.4% | +0.5% |
PTCT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +213.1% | -19.7% | +403.7% |
| 5 y | 5 years | at high | +250.4% | -19.7% | +403.7% |
| alltime | all time | at high | >+9999.0% | -19.7% | >+9999.0% |
PTC Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $526.00 M(-19.7%) |
| June 2024 | - | $654.78 M(+19.4%) |
| Mar 2024 | - | $548.36 M(-7.7%) |
| Dec 2023 | $594.00 M(+112.3%) | $594.00 M(+259.7%) |
| Sept 2023 | - | $165.16 M(-20.7%) |
| June 2023 | - | $208.39 M(+24.4%) |
| Mar 2023 | - | $167.50 M(-40.1%) |
| Dec 2022 | $279.83 M(+47.5%) | $279.83 M(+168.0%) |
| Sept 2022 | - | $104.42 M(-34.0%) |
| June 2022 | - | $158.16 M(+9.7%) |
| Mar 2022 | - | $144.18 M(-24.0%) |
| Dec 2021 | $189.72 M(-9.1%) | $189.72 M(-0.1%) |
| Sept 2021 | - | $189.82 M(+7.0%) |
| June 2021 | - | $177.35 M(+20.9%) |
| Mar 2021 | - | $146.63 M(-29.8%) |
| Dec 2020 | $208.81 M(-27.5%) | $208.81 M(-51.9%) |
| Sept 2020 | - | $433.97 M(+173.9%) |
| June 2020 | - | $158.46 M(+28.5%) |
| Mar 2020 | - | $123.29 M(-57.2%) |
| Dec 2019 | $288.03 M(+69.9%) | $288.03 M(-45.0%) |
| Sept 2019 | - | $523.58 M(+284.7%) |
| June 2019 | - | $136.09 M(-32.3%) |
| Mar 2019 | - | $201.14 M(+18.7%) |
| Dec 2018 | $169.50 M | $169.50 M(-18.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $206.91 M(-7.5%) |
| June 2018 | - | $223.79 M(+129.1%) |
| Mar 2018 | - | $97.67 M(-12.6%) |
| Dec 2017 | $111.79 M(+91.7%) | $111.79 M(-21.2%) |
| Sept 2017 | - | $141.84 M(+6.6%) |
| June 2017 | - | $133.01 M(+145.8%) |
| Mar 2017 | - | $54.11 M(-7.2%) |
| Dec 2016 | $58.32 M(+0.5%) | $58.32 M(+16.0%) |
| Sept 2016 | - | $50.29 M(+41.0%) |
| June 2016 | - | $35.66 M(-11.2%) |
| Mar 2016 | - | $40.16 M(-30.8%) |
| Dec 2015 | $58.02 M(+16.6%) | $58.02 M(-58.8%) |
| Sept 2015 | - | $140.71 M(+381.6%) |
| June 2015 | - | $29.22 M(-20.7%) |
| Mar 2015 | - | $36.83 M(-26.0%) |
| Dec 2014 | $49.75 M(+222.7%) | $49.75 M(-5.9%) |
| Sept 2014 | - | $52.87 M(+149.7%) |
| June 2014 | - | $21.17 M(-81.7%) |
| Mar 2014 | - | $115.86 M(+651.6%) |
| Dec 2013 | $15.41 M(+465.5%) | $15.41 M(-35.9%) |
| Sept 2013 | - | $24.04 M(-84.4%) |
| June 2013 | - | $154.10 M(+181.5%) |
| Mar 2013 | - | $54.75 M(+1908.5%) |
| Dec 2012 | $2.73 M(-90.4%) | $2.73 M |
| Dec 2011 | $28.43 M | - |
FAQ
- What is PTC Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PTC Therapeutics?
- What is PTC Therapeutics annual cash & cash equivalents year-on-year change?
- What is PTC Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for PTC Therapeutics?
- What is PTC Therapeutics quarterly cash and cash equivalents year-on-year change?
What is PTC Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of PTCT is $594.00 M
What is the all time high annual cash & cash equivalents for PTC Therapeutics?
PTC Therapeutics all-time high annual cash & cash equivalents is $594.00 M
What is PTC Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, PTCT annual cash & cash equivalents has changed by +$314.17 M (+112.27%)
What is PTC Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PTCT is $526.00 M
What is the all time high quarterly cash and cash equivalents for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash and cash equivalents is $654.78 M
What is PTC Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, PTCT quarterly cash and cash equivalents has changed by +$360.84 M (+218.49%)